The Next Evolution of Healthcare Private Equity

The rapidly changing healthcare landscape is presenting private equity investors with new opportunities. Which subsectors are most ripe for disruption, where do investors expect to see the biggest growth over the next several years and how can contributions from PE drive better outcomes across the industry?

To find out, WSJ Intelligence surveyed PE investors across the globe and, in collaboration with McDermott Will & Emery, developed a report of the findings. Complete this form to download the free report.

Among the key findings you'll discover in the report:

Health IT and telehealth stands out as the subsector that will attract the most attention from PE investors over the next three years.
Nearly three-quarters of respondents (74%) strongly or somewhat agree that “the healthcare sector was ripe for structural change prior to the onset of the pandemic, which has accelerated opportunities for investing in new modes of healthcare delivery.”
A majority of respondents say PE has driven interest in biopharma investments that support the creation of COVID-19 vaccines and therapies (62%) and helped fill the gap between in-hospital and out-of-hospital care (59%).

Survey participants included managing directors, chief investment officers and partners of private equity firms, the majority of which have $10 billion-$100 billion in assets under management.

First Name*

Last Name*

Email Address*

Company*

State or Province*

Country*

I would like to subscribe to future McDermott Private Equity updates.

I would like to discuss my legal needs with a McDermott lawyer.

I would like to be included in further discussions of the report findings.